H-1B sponsorship profile: Center for Breakthrough Medicines Holdings, LLC. Across U.S. Department of Labor LCA disclosures, Center for Breakthrough Medicines Holdings, LLC filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2024 and fiscal year 2025. The employer’s DOL certification rate sits at 66.7% (2 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Center for Breakthrough Medicines Holdings, LLC’s H-1B petitions range from $45,781 at the low end to $73,070 at the high end, with a petition-weighted average of $59,426. That range reflects the mix of occupations the company sponsors, led by Director of Microbiology (2 petitions at $76,029,335 avg), followed by Associate Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Center for Breakthrough Medicines Holdings, LLC is headquartered in King of Prussia, PA under NAICS code 325412, and places H-1B workers across 1 state, most heavily in PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Center for Breakthrough Medicines Holdings, LLC ranks. By H-1B petition volume, Center for Breakthrough Medicines Holdings, LLC is #37,433 of 119,880 employers nationally and #1,111 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.